Melanoma: all 3,073 studies
Page 3 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.
- Observational Study of Patients with Advanced Melanoma (skin Cancer) to Assess If IOpener®-melanoma Test Can Predict Response to Immunotherapy.RecruitingNCT06784778
- T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic MelanomaRecruitingNCT06783270Phase 1
- Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma PatientsNot yet recruitingNCT06780397
- Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic MelanomaRecruitingNCT06774989
- Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory MelanomaRecruitingNCT06771544Phase 2
- EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control TrialRecruitingNCT06767332Not applicable
- The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.RecruitingNCT06765850
- Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph NodeRecruitingNCT06754904Not applicable
- Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any HistotypeRecruitingNCT06753136Not applicable
- Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory ApprovalAvailableNCT06751524
- Combination Immunotherapy Targeting MelanomaNot yet recruitingNCT06739226Phase 1/2
- A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic MelanomaRecruitingNCT06727630Phase 1/2
- Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain MetastasesRecruitingNCT06712927Phase 2
- Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV MelanomaNot yet recruitingNCT06710093
- HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid TumoursRecruitingNCT06708663Phase 1/2
- Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 MelanomaNot yet recruitingNCT06708455Phase 2
- A Study of GC101 TIL in Advanced MelanomaRecruitingNCT06703398Phase 2
- The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in OncologyRecruitingNCT06685562
- Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)RecruitingNCT06683755Phase 1/2
- Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young AdultsRecruitingNCT06680323
- Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant AppRecruitingNCT06675643
- Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal CancerNot yet recruitingNCT06670300Phase 2
- DermaSensor Postmarket Surveillance StudyRecruitingNCT06666790Not applicable
- An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.Not yet recruitingNCT06661577
- Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)RecruitingNCT06660420Phase 1
- NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV MelanomaRecruitingNCT06651151Phase 2
- Evaluation of a Personalised Survivorship Care Plan App for Patients With MelanomaRecruitingNCT06643286Not applicable
- A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric CancerRecruitingNCT06636435Phase 1
- Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)RecruitingNCT06630611Phase 2
- Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma ManagementRecruitingNCT06627595
- Tebentafusp-tebn With LDT in Metastatic UMRecruitingNCT06626516Phase 1/2
- A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory MelanomaRecruitingNCT06624644Phase 2/3
- LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced MelanomaRecruitingNCT06623461Phase 2
- Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young AdultsRecruitingNCT06621810
- Precision Medicine for L/GCMN and Melanoma 1RecruitingNCT06608420
- CARDiac Toxicity Following ImmunOtherapy Treatment for MelanomaEnrolling by invitationNCT06605833
- Precision Medicine for L/GCMN and Melanoma 2RecruitingNCT06605443
- Understanding the Transition from Normal Melanocytes to Nevus to MelanomaRecruitingNCT06605417
- Pan-tumor MRD StudyRecruitingNCT06605404
- MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3)RecruitingNCT06602648
- Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic NeviRecruitingNCT06599619
- Safety and Efficacy of BA1302 in Patients With Advanced Solid TumorsRecruitingNCT06596915Phase 1
- Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)RecruitingNCT06586593
- A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal MelanomaRecruitingNCT06581406Phase 2/3
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Gene Expression Profiles and ctDNA for Risk Stratification in Patients With MelanomaNot yet recruitingNCT06566404
- Preoperative Planning With PSMA-PET in Melanoma Surgery TrialRecruitingNCT06560905Phase 2
- A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced MelanomaNot yet recruitingNCT06553781Not applicable
- Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFEDRecruitingNCT06548789Phase 2
- Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)RecruitingNCT06545682Phase 1
- Personalised Immunotherapy PlatformRecruitingNCT06536257
- Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual DiseaseRecruitingNCT06529822Phase 1
- PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver MetastasesRecruitingNCT06519266Phase 3
- Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene TherapiesRecruitingNCT06508775Not applicable
- Safety and Efficacy of KLS-1 Monotherapy in Malignant NeoplasmsRecruitingNCT06506643Phase 1/2
- Identification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot StudyNot yet recruitingNCT06493786Not applicable
- In Vivo Liquid Biopsy of Melanoma (Cytophone)RecruitingNCT06488365Not applicable
- FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable MelanomaRecruitingNCT06472661Early Phase 1
- Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor TherapyNot yet recruitingNCT06470880Phase 2
- A Study of VET3-TGI in Patients With Solid TumorsRecruitingNCT06444815Phase 1
- Rural Adult and Youth Sun Protection StudyRecruitingNCT06439979Not applicable
- Safety and Tolerability Study of GIM-531 in Advanced Solid TumorsRecruitingNCT06425926Phase 1/2
- A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal MelanomaEnrolling by invitationNCT06424626Phase 1
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsRecruitingNCT06418204
- LATe TreatmENT Related Toxicity in Melanoma (LATENT)Not yet recruitingNCT06414343
- A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their BodyRecruitingNCT06413680Phase 1/2
- Identification of Metabolic Phenotypes Associated With Melanoma MetastasisRecruitingNCT06400550
- R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid TumorsRecruitingNCT06398418Phase 1
- WoW - Single- vs Two-staged Excisions of Thin MelanomaRecruitingNCT06363591Not applicable
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab MonotherapyRecruitingNCT06362369Phase 1/2
- A Study of ST-1898 for Unresectable or Metastatic MelanomaRecruitingNCT06359860Phase 1/2
- Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLCRecruitingNCT06332755Phase 1
- A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)RecruitingNCT06330064Phase 1/2
- Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy FailureNot yet recruitingNCT06327698Phase 2
- A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsRecruitingNCT06326411Phase 1
- Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk MelanomaRecruitingNCT06319196Phase 2
- 177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsRecruitingNCT06305962Early Phase 1
- MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns]RecruitingNCT06299878
- High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO TrialRecruitingNCT06298734Not applicable
- Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced MelanomaRecruitingNCT06295159Phase 2
- Shared Decision Making in Melanoma Patients Receiving Adjuvant TherapyRecruitingNCT06294379
- Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma PatientsRecruitingNCT06284590Phase 2
- Uveal Melanoma - Comparative StudyRecruitingNCT06284512
- Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma PatientsNot yet recruitingNCT06281912
- Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal MelanomaRecruitingNCT06280040
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 1
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramRecruitingNCT06265285Phase 2
- GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsRecruitingNCT06265025Phase 1/2
- Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted TherapiesRecruitingNCT06254196Not applicable
- Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With PembrolizumabRecruitingNCT06249048Phase 1/2
- A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)RecruitingNCT06246916Phase 3
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- Intradermal Ipilimumab and Nivolumab in High Risk Stage II MelanomaRecruitingNCT06240143Phase 1/2
- ERK Inhibitor JSI-1187 in Advanced Solid TumorsRecruitingNCT06239623Phase 1
- Metastatic Melanoma Patients on Immunotherapy With Nutritive Intervention Based on Mediterranean DietRecruitingNCT06236360Not applicable
- Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS MutationsRecruitingNCT06229340Phase 2
- EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin CancersRecruitingNCT06223659Phase 2
- RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node MetastasisRecruitingNCT06216938Early Phase 1
- Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection MelanomaNot yet recruitingNCT06212388Early Phase 1
- AMT-253 in Patients With Advanced Solid TumoursRecruitingNCT06209580Phase 1/2